A featured talk held at the AIA Life Insurance Hong Kong (Tsim Sha Tsui), comparing the difference between stem cells therapy and targeted peptide therapy. Stem cell therapy is beneficial for certain diseases. However, due to the nature of the unspecialized cells, stem cells are used at a risk of being rejected after transplantation. The process might cause infections and organ dysfunction. Targeted peptide therapy, on the other hand, stimulates production of specific endogenous proteins making it a safe and effective method of treatment.
